27
Participants
Start Date
June 13, 2019
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
eryaspase (L-asparaginase encapsulated in red blood cells)
IV infusion 100 U/kg
Gemcitabine
IV infusion 1000 mg/m2
Carboplatin
IV infusion AUC2
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok
Bacs Kiskun Megyei Korhaz, Kecskemét
ZNA Middelheim, Antwerp
Institut Jules Bordet, Brussels
UZ Brussel, Brussels
Grand Hôpital de Charleroi asbl, Charleroi
Clinique Sainte-Elisabeth, Namur
Debreceni Egyetem - Klinikai Kozpont - Onkologiai Klinika, Debrecen
Complejo Hospitalario Universitario A Coruña, A Coruña
Hospital Universitario Germans Trias i Pujol, Badalona
Hospital Universitario Arnau Vilanova, Lleida
Fundacion Jimenez Diaz, Madrid
Hospital Clinico San Carlos, Madrid
Hospital Universitario Quirón Madrid, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Virgen del Rocio, Seville
Lead Sponsor
ERYtech Pharma
INDUSTRY